Skip to main content
OpenTrials
Completed

NCT Number: NCT05222490

FeetSee Thermal Images Collection Protocol

The purpose of this study is to collect thermal images of diabetic patients' feet to evaluate the performance of Feetsee - foot monitoring device for periodic evaluation of the temperature over the soles of the feet for signs of inflammation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Inlita Santara CTC

Vilnius, Lithuania

About this study

The aim of this study is to collect a database of thermal images of the diabetic persons' feet, and non-diabetic control groups' feet images, which in turn will enable us to build a system based on a mobile thermal camera and a mobile application for possible indication of signs of inflammation in feet. Enrolled participants will undergo a detailed history and physical examination of the foot at the beginning of the procedure day. Then the thermal images of the patient's feet will be taken. Participants will be also asked to take thermal images of their feet according to very well-explained instructions provided by the sponsor. Thermal images using the reference thermal camera will be taken following the Feetsee thermal camera. The images will be unidentified, collected, and stored for the development and performance evaluation of the Feetsee device Algorithm. At the end of the study procedure, participants or their caregivers will receive a short questioner on their experience with using the study device.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Inclusion criteria

Group 1/2: Diabetic with/without ulcers

  • Male/Female, 18 years or older
  • Diagnosis of type 1 or type 2 Diabetes Mellitus, confirmed by a family physician or an endocrinologist.
  • Patient with or without history of previous foot ulcer, confirmed by a family physician or an endocrinologist
  • For Group 1: Patient with diabetic foot and ulceration diagnosed/confirmed by the study physician on the day of enrollment For Group 2: Patient without ulcers diagnosed/confirmed by the study physician on the day of enrollment
  • Must be able to read, understand and sign the Informed Consent Form Control: Generally Healthy Non-diabetic
  • Male/Female, 18 years or older 2. No diabetes mellitus or other diseases that may have signs of polyneuropathy or impaired blood circulation in the foot. 3.No damage to the skin or the soft tissues of the examined feet. 4. Must be able to read, understand and sign the Informed Consent Form

Exclusion criteria

  • Critical ischemia and/or deep ulceration (grades 4 or 5 according to Texas grading system).
  • Active Infection/Gangrene
  • Active malignancy
  • Immunosuppressive disease
  • History of alcohol or drug abuse
  • Pregnant women (verbal confirmation or confirmation obtained within current medical records)
  • Cognitive deficit
  • End-stage renal disease
  • History of amputation proximal to the Trans-metatarsal (TM) joint
  • Other issues that, at the discretion of the investigator, renders the subject ineligible for participation.

Treatment and study plan

Thermal Camera images acquisition - FeetSee

Device

Thermal images will be collected according to the instructions for use of the Feetsee device.

Thermal Camera images acquisition - Reference

Device

After 15 minutes of resting, thermal images from the reference device will be collected according to their manufacturer

Primary outcomes

  1. Estimate of a difference in temperature between two feet per subject

    Time frame: through study completion, on average within of 1 year

    The primary outcome of this study is collecting of adequate thermal images from study groups' individuals using Feetsee device in order to develop and evaluate its performance to detect a temperature difference between two foot as a potential sign of inflammation and compare the camera performance to the reference camera.

Secondary outcomes

  1. To evaluate the usability of FeeSee device by patient and healthcare providers

    Time frame: through study completion, an average of 1 year

    The evaluation of Feetsee device usability by patients or their healthcare providers using a a dedicated usability questioner.

Sponsors and collaborators

Lead sponsor

Diabetis JSC

Industry

Registry information

Official study title

Collection of the Thermal Images of Diabetic Patients' Feet for FeetSee Device Performance Evaluation

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Feb 3, 2022
Registry last updated
Aug 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.